Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 30;9(4):941.
doi: 10.3390/jcm9040941.

Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis

Israel Júnior Borges do Nascimento  1 , Nensi Cacic  2 , Hebatullah Mohamed Abdulazeem  3 , Thilo Caspar von Groote  4 , Umesh Jayarajah  5 , Ishanka Weerasekara  6   7 , Meisam Abdar Esfahani  8 , Vinicius Tassoni Civile  9 , Ana Marusic  2 , Ana Jeroncic  2 , Nelson Carvas Junior  10 , Tina Poklepovic Pericic  2 , Irena Zakarija-Grkovic  2 , Silvana Mangeon Meirelles Guimarães  1 , Nicola Luigi Bragazzi  11 , Maria Bjorklund  12 , Ahmad Sofi-Mahmudi  8 , Mohammad Altujjar  13 , Maoyi Tian  14   15 , Diana Maria Cespedes Arcani  16 , Dónal P O'Mathúna  17   18 , Milena Soriano Marcolino  1
Affiliations

Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis

Israel Júnior Borges do Nascimento et al. J Clin Med. .

Abstract

A growing body of literature on the 2019 novel coronavirus (SARS-CoV-2) is becoming available, but a synthesis of available data has not been conducted. We performed a scoping review of currently available clinical, epidemiological, laboratory, and chest imaging data related to the SARS-CoV-2 infection. We searched MEDLINE, Cochrane CENTRAL, EMBASE, Scopus and LILACS from 01 January 2019 to 24 February 2020. Study selection, data extraction and risk of bias assessment were performed by two independent reviewers. Qualitative synthesis and meta-analysis were conducted using the clinical and laboratory data, and random-effects models were applied to estimate pooled results. A total of 61 studies were included (59,254 patients). The most common disease-related symptoms were fever (82%, 95% confidence interval (CI) 56%-99%; n = 4410), cough (61%, 95% CI 39%-81%; n = 3985), muscle aches and/or fatigue (36%, 95% CI 18%-55%; n = 3778), dyspnea (26%, 95% CI 12%-41%; n = 3700), headache in 12% (95% CI 4%-23%, n = 3598 patients), sore throat in 10% (95% CI 5%-17%, n = 1387) and gastrointestinal symptoms in 9% (95% CI 3%-17%, n = 1744). Laboratory findings were described in a lower number of patients and revealed lymphopenia (0.93 × 109/L, 95% CI 0.83-1.03 × 109/L, n = 464) and abnormal C-reactive protein (33.72 mg/dL, 95% CI 21.54-45.91 mg/dL; n = 1637). Radiological findings varied, but mostly described ground-glass opacities and consolidation. Data on treatment options were limited. All-cause mortality was 0.3% (95% CI 0.0%-1.0%; n = 53,631). Epidemiological studies showed that mortality was higher in males and elderly patients. The majority of reported clinical symptoms and laboratory findings related to SARS-CoV-2 infection are non-specific. Clinical suspicion, accompanied by a relevant epidemiological history, should be followed by early imaging and virological assay.

Keywords: COVID-19; SARS-CoV-2; meta-analysis; novel coronavirus; scoping review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Prisma flow diagram.
See this image and copyright information in PMC

Comment in

References

    1. Lu H., Stratton C.W., Tang Y.W. Outbreak of pneumonia of unknown etiology in Wuhan China: The mystery and the miracle. J. Med. Virol. 2020;92:401–402. doi: 10.1002/jmv.25678. - DOI - PMC - PubMed
    1. World Health Organization . Coronavirus Disease 2019 (COVID-19): Situation Report—38. World Health Organization; Geneva, Switzerland: 2020.
    1. World Health Organization . Statement on the Second Meeting of the International Health Regulations (2005) World Health Organization; Geneva, Switzerland: 2020. Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV)
    1. Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H., Wu Y., Zhang L., Yu Z., Fang M., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 2020 doi: 10.1016/S2213-2600(20)30079-5. - DOI - PMC - PubMed
    1. World Health Organization Naming the Coronavirus Disease (COVID-2019) and the Virus that Causes It. [(accessed on 1 March 2020)];2020 Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technica....

Publication types